×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
导航切换
Journal of International Oncology
Home
About Journal
About Journal
Journal History
Objective
Editorial Committee
Editorial Boards
Communications Editorial Board
Introduction to Editor-in-Chief
General Principles of the Editorial Board
Guide for Authors
Online Submission Guide
Instructions for Authors
Publication Ethics
Aim and Scope
Subscribe
Contacts Us
中文
Study on the difference of sunitinib and sorafenib as firstline treatment in advanced renal carcinoma
Dai Xing, Ba Nan, Yan Lin
Journal of International Oncology . 2016, (
1
): 8 -11 . DOI: 10.3760/cma.j.issn.1673-422X.2016.01.003
